GPW
GSK icon

Genesis Private Wealth’s GSK GSK Stock Holding History

Genesis Private Wealth’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-4,828
Closed -$237K – 190
2025
Q4 		$237K Sell
4,828
-1,172
-20% -$54.7K 0.07% 155
2025
Q3 		$259K Sell
6,000
-47
-0.8% -$1.84K 0.11% 117
2025
Q2 		$232K Buy
+6,047
New +$231K 0.11% 130

Other funds holding GSK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Genesis Private Wealth's GSK Position: Q1 2026 in Review

Genesis Private Wealth sold out of GSK (GSK) in Q1 2026, closing a stake of 4,828 shares — an estimated $237K sold.

Genesis Private Wealth first reported a position in GSK in Q2 2025 and held it in 3 quarters. The position peaked at $259K in Q3 2025. 1,031 funds tracked by Wall St. Rank hold GSK as of Q1 2026.

  • Genesis Private Wealth reported no remaining GSK position as of Q1 2026 after selling out during the quarter.
  • Genesis Private Wealth sold 4,828 GSK shares in Q1 2026, an estimated $237K.
  • Genesis Private Wealth first reported a position in GSK in Q2 2025 and held it in 3 quarters.
  • Genesis Private Wealth's GSK position peaked at $259K in Q3 2025.
  • 1,031 funds tracked by Wall St. Rank held GSK as of Q1 2026.

Based on Genesis Private Wealth's 13F filing for Q1 2026, filed 16 Apr 2026.